Buprenorphine treatment: Factors and first-hand experiences for providers to consider

被引:1
|
作者
Meier, Bradley R.
Patkar, Ashwin A.
机构
[1] Thomas Jefferson Univ, Dept Psychiat, Div Substance Abuse Programs, Philadelphia, PA 19107 USA
[2] Duke Univ, Dept Psychiat & Behav Sci Biol Psychiat, Durham, NC USA
关键词
buprenorphine; opiate dependence; FDA; Subulex (R); Suboxone (R); ADDICTION SEVERITY INDEX; METHADONE-MAINTENANCE TREATMENT; OFFICE-BASED TREATMENT; OPIOID DEPENDENCE; SUBLINGUAL-TABLET; DETOXIFICATION; BLOCKADE; ABUSE;
D O I
10.1300/J069v26n01_02
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The viability of using buprenorphine to treat opiate dependence was well documented prior to federal approval in October 2002. What has been lacking in the literature is "hands-on" experience of providers from a clinical management and practice management perspective. This article adds to the knowledge base by providing information about buprenorphine treatment as well as anecdotes from patients treated by the authors, leading to a detailed list of factors worth considering for the treatment provider contemplating adding an opiate-addicted population to an existing treatment base.
引用
收藏
页码:3 / 14
页数:12
相关论文
共 50 条